3-Methyl-1-(6-methyl-1H-benzimidazol-2-yl)-4-(phenylmethyl)-1H-pyrazol-5-ol, commonly known as MMMP, is a heterocyclic ring Compound, belonging to benzimidazole derivatives. MMMP is considered a promising scaffold with bioactive and pharmacological properties that warrants further investigation.
MMMP exhibits potent antimicrobial activity against a variety of pathogenic microorganisms, including bacteria, fungi, and protozoa, making it a potential candidate for pharmaceuticals, personal care products, and agricultural applications. MMMP has significant antioxidant properties, capable of scavenging free radicals and preventing oxidative damage to cells and tissues. MMMP exerts anti-inflammatory effects by modulating inflammatory pathways and inhibiting the release of pro-inflammatory mediators such as cytokines and chemokines. MMMP has shown promising anticancer potential in preclinical studies through its ability to inhibit cancer cell proliferation, induce apoptosis, and inhibit tumor growth. MMMPs exert neuroprotective effects by attenuating neuronal damage, reducing oxidative stress, and promoting neuronal survival in various neurodegenerative and neurological disorders. Its ability to cross the blood-brain barrier and modulate neuronal function makes it a promising candidate for treating diseases such as Alzheimer's disease, Parkinson's disease and ischemic stroke.
|